Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study
Open Access
- 11 April 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (7), 1347-1349
- https://doi.org/10.1093/ndt/gfab155
Abstract
Timna Agur, Naomi Ben-Dor, Shira Goldman, Shelly Lichtenberg, Michal Herman-Edelstein, Dafna Yahav, Benaya Rozen-Zvi, Boris Zingerman; Antibody response to mRNAKeywords
This publication has 13 references indexed in Scilit:
- The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to actionKidney International, 2021
- Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we needSignal Transduction and Targeted Therapy, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTANephrology Dialysis Transplantation, 2020
- Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney TransplantationAmerican Journal of Kidney Diseases, 2020
- Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysisJournal of Nephrology, 2019
- Serum albumin level as an indicator of response to Hepatitis B vaccination in dialysis patients: A systematic review and meta-analysis2017
- Is there any survival advantage of obesity in Southern European haemodialysis patients?Nephrology Dialysis Transplantation, 2009
- Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapyInternational Journal of Clinical Practice, 2009
- Vaccination and chronic kidney diseaseNephrology Dialysis Transplantation, 2007